H-1B Filings
38
DOL labor condition applications on file
Novartis Pharmaceuticals CORPORATION in NJ (Professional & Technical Services) shows all three federal tracks on this profile: 38 H-1B LCAs, an employer OSHA injury record, and 42 WARN notices.
Novartis Pharmaceuticals CORPORATION (NJ): · 38 H-1B LCAs at a $141,170 disclosed median · OSHA Grade A (DART 0.05) · 42 WARN notices
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Novartis Pharmaceuticals CORPORATION in NJ carries 38 H-1B wage filings on record, a $141,170 median wage across 34 disclosed-wage positions (above the $120,000 national median), a strong A OSHA safety grade and 42 WARN layoff notices on file. H-1B filing volume ranks #701 of 36,919 sponsors in this corpus (about the 98th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.
Layoff & federal record
According to U.S. Department of Labor, OSHA, and state WARN Act filings, Novartis Pharmaceuticals CORPORATION carries 38 H-1B wage filings on record, a $141,170 median wage across 34 disclosed-wage positions (above the $120,000 national median), a strong A OSHA safety grade and 42 WARN layoff notices on file. In this corpus, H-1B filing volume ranks #701 of 36,919 sponsors in this corpus (about the 98th percentile), and disclosed median wage sits at the 66th percentile of 178,031 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs, this employer's OSHA injury log, and state WARN notices, three independent disclosure systems.
DOL LCA release change
H-1B Filings
38
DOL labor condition applications on file
Median H-1B Salary
$141,170
Across 34 disclosed positions
OSHA Safety Grade
Grade A · DART 0.05
vs 0.27 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
WARN Workforce Impact
3,639 workers
42 WARN Act notices on file
Where Novartis Pharmaceuticals CORPORATION's H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$141,170 Top 34% higher than 66% of 178,031 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (+0.5% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | Novartis Pharmaceuticals CORPORATION | DOL OFLC / OSHA / WARN |
| Industry | Professional & Technical Services | NAICS / DOL |
| State | NJ | U.S. Federal Records |
| H-1B Filings | 38 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $141,170 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | A | OSHA ITA |
| OSHA DART Rate | 0.05 | OSHA ITA Establishment Records |
| WARN Layoff Notices | 42 notice(s), 3,639 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
Novartis Pharmaceuticals CORPORATION's values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records, WARN Act notices on file for this employer in NJ (Professional & Technical Services).
| Job Title | Median |
|---|---|
| Executive Director, Forecasting | $241,592 |
| Director, AI Engineering | $223,642 |
| AD,Software Architect,Full Stack,RWD Sol | $187,741 |
| Associate Director, Web Platform Ops & Solutions Designs | $186,056 |
| Sr. Global Program Safety Lead | $183,186 |
| Associate Director, Product Adoption | $170,373 |
| Director, Integrated Analytics (Renal) | $170,373 |
| Associate Director, Business Performance | $169,541 |
| Director, Integrated Field Insights & Analytics | $169,541 |
| Director, BD&L, Insights and Decision Science | $169,541 |
| Sr. Principal AQS Tech & Scientific Com | $161,803 |
| Director, Medical Science Liaison | $161,138 |
| Associate Director, NPS Product Management | $158,974 |
| Associate Director Patient Marketing Vijoice | $156,894 |
| Senior Principal Biostatistician | $142,771 |
| R&D/Tech Dev Quality Lead, Compliance | $142,730 |
| Associate Director, Commercial Analytics | $141,170 |
| Associate Director, Product Management | $141,170 |
| Associate Director, Resource Optimization | $141,170 |
| Associate Director, Emerging Data Products | $139,506 |
| Principal Biostatistician | $133,904 |
| Associate Director, Business Applications Product Owner | $126,818 |
| Senior Manager, Functional Reporting | $126,818 |
| Associate Director Solution Delivery Clinical Analytics | $121,514 |
| Associate Director, PM QA | $118,435 |
| Expert Science & Technology | $114,109 |
| Director, US Forecasting | $111,966 |
| Senior Manager, PSC Operations Insights | $111,966 |
| Trial Vendor Senior Manager | $111,966 |
| Associate Director, Performance Reporting | $109,491 |
| Manager, Performance Reporting | $109,491 |
| Sr. Multi-Discipline Engineer | $107,952 |
| Sr Expert, Science & Technology (Drug Product-Product Lead) | $99,757 |
| Analyst, PSC Workforce Management | $94,557 |
Novartis Pharmaceuticals CORPORATION operating in NJ within the Professional & Technical Services sector: the company has filed 38 H-1B labor condition applications, of which 34 disclose a usable wage figure with a median of $141,170. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.
On workplace safety, Novartis Pharmaceuticals CORPORATION posted a DART (Days Away, Restricted, Transferred) rate of 0.05 injuries per 100 full-time workers, compared with the hours-weighted average of 0.27 for the same 2-digit NAICS sector in OSHA ITA 2022–2023 filings. Our composite grade of "A" is that employer-to-sector ratio (A ≤0.5× sector · B ≤0.8× · C ≤1.2× · D ≤1.8× · else F), so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 11 reportable injuries at this employer.
42 WARN Act notices affecting 3,639 workers have been filed against Novartis Pharmaceuticals CORPORATION in NJ. Multiple notices can mean consolidations or broader restructuring; weigh them next to this employer's pay and safety signals, and the employer's own disclosures, when judging an offer.
Novartis Pharmaceuticals CORPORATION is one of the rarer profiles that carries both sponsorship volume (38 H-1B LCAs) and WARN history (42 notices) in the same public record for Professional & Technical Services in NJ. Weigh those two signals separately before treating either as the whole story.
Novartis Pharmaceuticals CORPORATION's DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Professional & Technical Services).
Total reported injuries on file: 11.
Novartis Pharmaceuticals CORPORATION's nearest H-1B-filing peers in Professional & Technical Services (home state NJ). Each card links to that employer's federal-records profile.
| Notice Date | Workers |
|---|---|
| 2023-08-01 | 103 |
| 2022-11-01 | 221 |
| 2021-06-01 | 186 |
| 2014-12-01 | 200 |
| 2014-04-01 | 47 |
| 2014-04-01 | 38 |
| 2014-04-01 | 38 |
| 2014-04-01 | 32 |
| 2014-04-01 | 15 |
| 2014-04-01 | 10 |
| 2014-04-01 | 9 |
| 2014-04-01 | 3 |
| 2014-04-01 | 2 |
| 2014-04-01 | 2 |
| 2014-04-01 | 2 |
| 2014-04-01 | 1 |
| 2014-04-01 | 1 |
| 2014-04-01 | 1 |
| 2014-04-01 | 1 |
| 2014-03-01 | 2 |
| 2014-02-01 | 2 |
| 2014-02-01 | 561 |
| 2014-02-01 | 23 |
| 2014-02-01 | 8 |
| 2014-02-01 | 8 |
| 2014-02-01 | 4 |
| 2014-02-01 | 4 |
| 2014-02-01 | 2 |
| 2014-02-01 | 4 |
| 2012-04-01 | 1,380 |
| 2012-04-01 | 93 |
| 2012-04-01 | 45 |
| 2012-04-01 | 35 |
| 2012-04-01 | 32 |
| 2012-04-01 | 27 |
| 2012-04-01 | 5 |
| 2012-03-01 | 5 |
| 2012-02-01 | 14 |
| 2012-02-01 | 247 |
| 2012-01-01 | 43 |
| 2011-11-01 | 145 |
| 2011-11-01 | 38 |
What to check before working with Novartis Pharmaceuticals CORPORATION
Novartis Pharmaceuticals CORPORATION needs a three-way read: H-1B pay (38 LCAs), safety (grade A), and WARN history (42 notices); none of those alone is the rating.
Novartis Pharmaceuticals CORPORATION's figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings, OSHA Injury Tracking Application records and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.